
    
      Patients presenting to the participant Emergency Departments (ED) with a diagnosis of AECOPD
      and who receive at least one dose of albuterol, will be randomized to receive either placebo
      or one dose of MgSO4 2g IV. Security and efficacy outcomes will be measured.
    
  